Senseonics Holdings, Inc. Common Stock (SENS) Competitors

$5.71 -0.11 (-1.89%)

As of 02:13 PM Eastern

SENS vs. TRNS, CTKB, FEIM, LAB, and NAUT

Should you buy Senseonics Holdings, Inc. Common Stock stock or one of its competitors? MarketBeat compares Senseonics Holdings, Inc. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Senseonics Holdings, Inc. Common Stock include Transcat (TRNS), Cytek Biosciences (CTKB), Frequency Electronics (FEIM), Standard BioTools (LAB), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry.

How does Senseonics Holdings, Inc. Common Stock compare to Transcat?

Transcat (NASDAQ:TRNS) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

Transcat has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Transcat	$278.42M	2.49	$14.52M	$0.85	87.32
Senseonics Holdings, Inc. Common Stock	$35.26M	6.77	-$69.11M	-$2.00	N/A

In the previous week, Senseonics Holdings, Inc. Common Stock had 18 more articles in the media than Transcat. MarketBeat recorded 19 mentions for Senseonics Holdings, Inc. Common Stock and 1 mentions for Transcat. Transcat's average media sentiment score of 1.80 beat Senseonics Holdings, Inc. Common Stock's score of 0.76 indicating that Transcat is being referred to more favorably in the media.

Company	Overall Sentiment
Transcat	Very Positive
Senseonics Holdings, Inc. Common Stock	Positive

98.3% of Transcat shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 2.8% of Transcat shares are held by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Transcat currently has a consensus price target of $105.33, indicating a potential upside of 41.91%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.00, indicating a potential upside of 197.72%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Transcat.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Transcat	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Transcat has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

Transcat has a net margin of 2.47% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Transcat's return on equity of 6.15% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Transcat	2.47%	6.15%	4.15%
Senseonics Holdings, Inc. Common Stock	-213.87%	-129.97%	-67.14%

Summary

Transcat beats Senseonics Holdings, Inc. Common Stock on 9 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Cytek Biosciences?

Cytek Biosciences (NASDAQ:CTKB) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

69.5% of Cytek Biosciences shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 10.4% of Cytek Biosciences shares are held by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cytek Biosciences has a net margin of -36.25% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Cytek Biosciences' return on equity of -10.07% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytek Biosciences	-36.25%	-10.07%	-7.56%
Senseonics Holdings, Inc. Common Stock	-213.87%	-129.97%	-67.14%

Cytek Biosciences has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

Cytek Biosciences currently has a consensus price target of $5.69, indicating a potential upside of 61.35%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.00, indicating a potential upside of 197.72%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Cytek Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Cytek Biosciences has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Cytek Biosciences is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytek Biosciences	$201.49M	2.26	-$66.54M	-$0.57	N/A
Senseonics Holdings, Inc. Common Stock	$35.26M	6.77	-$69.11M	-$2.00	N/A

In the previous week, Senseonics Holdings, Inc. Common Stock had 15 more articles in the media than Cytek Biosciences. MarketBeat recorded 19 mentions for Senseonics Holdings, Inc. Common Stock and 4 mentions for Cytek Biosciences. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.76 beat Cytek Biosciences' score of -0.09 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cytek Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
Senseonics Holdings, Inc. Common Stock	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cytek Biosciences beats Senseonics Holdings, Inc. Common Stock on 9 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Frequency Electronics?

Frequency Electronics (NASDAQ:FEIM) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap measuring and control equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

58.6% of Frequency Electronics shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 28.0% of Frequency Electronics shares are held by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Frequency Electronics has a net margin of 10.78% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Frequency Electronics' return on equity of 12.69% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Frequency Electronics	10.78%	12.69%	7.84%
Senseonics Holdings, Inc. Common Stock	-213.87%	-129.97%	-67.14%

Frequency Electronics has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market.

Frequency Electronics currently has a consensus target price of $43.67, indicating a potential downside of 24.04%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.00, indicating a potential upside of 197.72%. Given Senseonics Holdings, Inc. Common Stock's higher probable upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Frequency Electronics has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Frequency Electronics	$69.81M	8.10	$23.69M	$0.75	76.65
Senseonics Holdings, Inc. Common Stock	$35.26M	6.77	-$69.11M	-$2.00	N/A

In the previous week, Senseonics Holdings, Inc. Common Stock had 15 more articles in the media than Frequency Electronics. MarketBeat recorded 19 mentions for Senseonics Holdings, Inc. Common Stock and 4 mentions for Frequency Electronics. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.76 beat Frequency Electronics' score of 0.57 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Frequency Electronics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Senseonics Holdings, Inc. Common Stock	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Frequency Electronics beats Senseonics Holdings, Inc. Common Stock on 11 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Standard BioTools?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Standard BioTools (NASDAQ:LAB) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

In the previous week, Senseonics Holdings, Inc. Common Stock had 18 more articles in the media than Standard BioTools. MarketBeat recorded 19 mentions for Senseonics Holdings, Inc. Common Stock and 1 mentions for Standard BioTools. Standard BioTools' average media sentiment score of 1.87 beat Senseonics Holdings, Inc. Common Stock's score of 0.76 indicating that Standard BioTools is being referred to more favorably in the news media.

Company	Overall Sentiment
Senseonics Holdings, Inc. Common Stock	Positive
Standard BioTools	Very Positive

Senseonics Holdings, Inc. Common Stock has higher earnings, but lower revenue than Standard BioTools. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senseonics Holdings, Inc. Common Stock	$35.26M	6.77	-$69.11M	-$2.00	N/A
Standard BioTools	$85.33M	4.50	-$74.90M	$0.20	4.92

Senseonics Holdings, Inc. Common Stock currently has a consensus target price of $17.00, indicating a potential upside of 197.72%. Standard BioTools has a consensus target price of $1.35, indicating a potential upside of 37.20%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, research analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Standard BioTools.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Standard BioTools	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Senseonics Holdings, Inc. Common Stock has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market. Comparatively, Standard BioTools has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market.

Standard BioTools has a net margin of 73.46% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Standard BioTools' return on equity of -8.18% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Senseonics Holdings, Inc. Common Stock	-213.87%	-129.97%	-67.14%
Standard BioTools	73.46%	-8.18%	-6.43%

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 53.7% of Standard BioTools shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Comparatively, 23.2% of Standard BioTools shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Standard BioTools beats Senseonics Holdings, Inc. Common Stock on 10 of the 17 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Nautilus Biotechnology?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

In the previous week, Senseonics Holdings, Inc. Common Stock had 17 more articles in the media than Nautilus Biotechnology. MarketBeat recorded 19 mentions for Senseonics Holdings, Inc. Common Stock and 2 mentions for Nautilus Biotechnology. Nautilus Biotechnology's average media sentiment score of 1.44 beat Senseonics Holdings, Inc. Common Stock's score of 0.76 indicating that Nautilus Biotechnology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Senseonics Holdings, Inc. Common Stock	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Nautilus Biotechnology	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Comparatively, 41.1% of Nautilus Biotechnology shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nautilus Biotechnology has lower revenue, but higher earnings than Senseonics Holdings, Inc. Common Stock. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senseonics Holdings, Inc. Common Stock	$35.26M	6.77	-$69.11M	-$2.00	N/A
Nautilus Biotechnology	N/A	N/A	-$59M	-$0.46	N/A

Senseonics Holdings, Inc. Common Stock has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market. Comparatively, Nautilus Biotechnology has a beta of 0.75, indicating that its share price is 25% less volatile than the broader market.

Senseonics Holdings, Inc. Common Stock currently has a consensus target price of $17.00, indicating a potential upside of 197.72%. Nautilus Biotechnology has a consensus target price of $4.00, indicating a potential upside of 61.10%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, research analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Nautilus Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Nautilus Biotechnology	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Nautilus Biotechnology has a net margin of 0.00% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Nautilus Biotechnology's return on equity of -35.04% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Senseonics Holdings, Inc. Common Stock	-213.87%	-129.97%	-67.14%
Nautilus Biotechnology	N/A	-35.04%	-29.16%

Summary

Senseonics Holdings, Inc. Common Stock and Nautilus Biotechnology tied by winning 8 of the 16 factors compared between the two stocks.

Get Senseonics Holdings, Inc. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SENS vs. The Competition

Export

Metric	Senseonics Holdings, Inc. Common Stock	Industrial Measurement Instruments & Related Products Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$238.68M	$13.19B	$4.19B	$12.35B
Dividend Yield	N/A	0.74%	6.42%	5.35%
P/E Ratio	-2.86	20.23	22.70	25.39
Price / Sales	6.77	4.71	154.69	73.15
Price / Cash	N/A	7.40	53.46	56.33
Price / Book	6.96	4.32	38.98	6.93
Net Income	-$69.11M	$81.56M	$113.55M	$333.88M
7 Day Performance	13.52%	11.43%	3.25%	0.03%
1 Month Performance	-17.25%	1.25%	5.03%	1.93%
1 Year Performance	N/A	-43.63%	16.80%	33.14%

Senseonics Holdings, Inc. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SENS Senseonics Holdings, Inc. Common Stock	3.2776 of 5 stars	$5.71 -1.9%	$17.00 +197.7%	N/A	$238.68M	$35.26M	N/A	90	Trending News Analyst Forecast Insider Trade Analyst Revision Gap Down
TRNS Transcat	3.185 of 5 stars	$75.16 -0.2%	$105.33 +40.1%	-2.4%	$702.99M	$278.42M	88.42	1,245	Positive News
CTKB Cytek Biosciences	1.9585 of 5 stars	$4.94 +3.3%	$5.38 +8.8%	+23.1%	$617.30M	$201.49M	N/A	500	Analyst Forecast
FEIM Frequency Electronics	1.5667 of 5 stars	$57.15 +1.7%	$43.67 -23.6%	+240.2%	$553.31M	$69.81M	76.20	200	News Coverage Gap Down
LAB Standard BioTools	3.1107 of 5 stars	$0.97 -1.1%	$1.35 +39.4%	-6.6%	$382.17M	$85.33M	N/A	620	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SENS) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Senseonics Holdings, Inc. Common Stock (SENS) Competitors

SENS vs. TRNS, CTKB, FEIM, LAB, and NAUT

How does Senseonics Holdings, Inc. Common Stock compare to Transcat?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Cytek Biosciences?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Frequency Electronics?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Standard BioTools?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Nautilus Biotechnology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SENS vs. The Competition

Senseonics Holdings, Inc. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Senseonics Holdings, Inc. Common Stock (SENS) Competitors

SENS vs. TRNS, CTKB, FEIM, LAB, and NAUT

How does Senseonics Holdings, Inc. Common Stock compare to Transcat?

Which has preferable earnings & valuation, TRNS or SENS?

Does the media favor TRNS or SENS?

Do insiders and institutionals believe in TRNS or SENS?

Do analysts recommend TRNS or SENS?

Which has more volatility & risk, TRNS or SENS?

Is TRNS or SENS more profitable?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Cytek Biosciences?

Do insiders and institutionals believe in CTKB or SENS?

Is CTKB or SENS more profitable?

Which has more volatility & risk, CTKB or SENS?

Do analysts recommend CTKB or SENS?

Which has preferable earnings & valuation, CTKB or SENS?

Does the media favor CTKB or SENS?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Frequency Electronics?

Do institutionals & insiders believe in FEIM or SENS?

Is FEIM or SENS more profitable?

Which has more volatility & risk, FEIM or SENS?

Do analysts prefer FEIM or SENS?

Which has higher earnings & valuation, FEIM or SENS?

Does the media favor FEIM or SENS?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Standard BioTools?

Does the media refer more to SENS or LAB?

Which has stronger earnings and valuation, SENS or LAB?

Do analysts prefer SENS or LAB?

Which has more risk & volatility, SENS or LAB?

Is SENS or LAB more profitable?

Do insiders and institutionals have more ownership in SENS or LAB?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Nautilus Biotechnology?

Does the media refer more to SENS or NAUT?

Do insiders and institutionals have more ownership in SENS or NAUT?

Which has stronger earnings and valuation, SENS or NAUT?

Which has more risk & volatility, SENS or NAUT?

Do analysts prefer SENS or NAUT?

Is SENS or NAUT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SENS vs. The Competition

Senseonics Holdings, Inc. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools